Atriopeptins stimulate cGMP synthesis in vascular smooth muscle and glomerular mesangial cells, supporting the hypothesis that cGMP mediates the cellular action of atrial natriuretic peptide.
SATO, M., ABE, K., TAKEUCHI, K., MATSUI, K., YASUJIMA, M., FANG, S., KANAZAWA, M., YOSHIDA, K., KIMURA, T. and YOSHINAGA, K. Cyclic GMP Accumulation by Atriopeptins in Cultured Rat Renal and Vascular Smooth Muscle Cells. Tohoku J. exp. Med., 1988, 154 (4), 399-411-To-evaluate the role of cyclic guanosine monophosphate (cGMP) in the vascular and renal action of atrial natriuretic peptide (ANP), we compared the effects of atriopeptins (APs) on cGMP accumulation in cultured cells from rat mesenteric vascular smooth muscle (VSM), glomerular mesangium (GM) and renal papillary collecting tubule (RPCT), and also evaluated the relationship between renal sodium or water excretion and urinary cGMP in AP-infused rats. Both AP I and AP III increased intracellular cGMP levels dose-dependently in all types of cells, while they did not affect intracellular cAMP levels or prostaglandin synthesis. AP III was 100 times more potent than AP I. The magnitude change in cGMP levels was largest in GM cells. The sensitivity of VSM and GM cells to AP III were greater than that of RPCT cells. There were significant positive relationships between urinary excretion of sodium or water and that of cGMP levels in AP-infused rats. These results may suggest that GM and VSM cells are the principal targets for ANP to stimulate cGMP synthesis and, possibly, to exert the renal sodium and water excretion, and also support the hypothesis that cGMP mediates the cellular action of ANP.
Sato et al. (1988) studied this question.